Pharmaceutical Preparations · CIK 1725160
Developing azenosertib, a WEE1 inhibitor, for ovarian cancer and other tumor types
Comparable business profile · signals at a glance
In the 90 days to Feb 10, 2026: 1 insider bought $7.8M · 4 sold $10.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Vultaggio VincentPAO and PFO | Sell | 6,894 | $2.42 | $17K |
| Feb 9, 2026 | Vultaggio VincentPAO and PFO | Sell | 3,379 | $2.39 | $8K |
| Feb 9, 2026 | Eastland Julia MarieCEO & President | Sell | 889 | $2.39 | $2K |
| Feb 9, 2026 | Bruns IngmarChief Medical Officer | Sell | 335 | $2.39 | $801 |
| Feb 6, 2026 | Vultaggio VincentPAO and PFO | Sell | 29,951 | $2.43 | $73K |
| Feb 6, 2026 | Eastland Julia MarieCEO & President | Sell | 7,866 | $2.43 | $19K |
| Feb 6, 2026 | Bruns IngmarChief Medical Officer | Sell | 2,962 | $2.43 | $7K |
| Feb 3, 2026 | Vultaggio VincentPAO and PFO | Sell | 556 | $2.52 | $1K |
| Feb 2, 2026 | Vultaggio VincentPAO and PFO | Sell | 2,540 | $2.55 | $6K |
| Dec 31, 2025 | Walters William ThurmanTenPercentOwner | Buy | 6,459,973 | $1.20 | $7.8M |
| Dec 15, 2025 | Goel David E.TenPercentOwner | Sell | 7,500,000 | $1.33 | $10.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.